Strain competition restricts colonization of an enteric pathogen and prevents colitis

EMBO Reports

Volumn 17, Issue 9, 2016, Pages 1281-1291

  Hecht, Aaron L ^a   Casterline, Benjamin W ^a   Earley, Zachary M ^a   Goo, Young Ah ^b   Goodlett, David R ^b   Bubeck Wardenburg, Juliane ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

colonization resistance; enterotoxigenic Bacteroides fragilis; in vivo strain competition; probiotics; type VI secretion

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CLINDAMYCIN; GENTAMICIN; KANAMYCIN; RIFAMPICIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; COLITIS; COLON FLORA; INTRASPECIFIC COMPETITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TYPE VI SECRETION SYSTEM;

EID: 84985014376     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201642282     Document Type: Article

References (41)

1. Chatzidaki-Livanis M, Coyne MJ, Comstock LE (2014) An antimicrobial protein of the gut symbiont Bacteroides fragilis with a MACPF domain of host immune proteins. Mol Microbiol 94: 1361–1374
2. Kommineni S, Bretl DJ, Lam V, Chakraborty R, Hayward M, Simpson P, Cao Y, Bousounis P, Kristich CJ, Salzman NH (2015) Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 526: 719–722
3. Sassone-Corsi M, Raffatellu M (2015) No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens. J Immunol 194: 4081–4087
4. Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13: 790–801
5. Lawley TD, Walker AW (2012) Intestinal colonization resistance. Immunology 138: 1–11
6. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76: 4726–4736
7. Leatham MP, Banerjee S, Autieri SM, Mercado-Lubo R, Conway T, Cohen PS (2009) Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine. Infect Immun 77: 2876–2886
8. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CGM (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 104: 7617–7621
9. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, Van Maele L, Sirard J-C, Mueller AJ, Heikenwalder M et al (2010) The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella Diarrhea. PLoS Pathog 6: e1001097
10. Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J (2000) Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerging Infect Dis 6: 171–174
11. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC et al (2015) The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 60: 208–215
12. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016–1022
13. Kato N, Kato H, Watanabe K, Ueno K (1996) Association of enterotoxigenic Bacteroides fragilis with bacteremia. Clin Infect Dis 23(Suppl 1): S83–S86
14. Sears CL (2009) Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev 22: 349–369
15. Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, Rabizadeh S, Golub JE, Mathews LE, Shin J et al (2009) Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun 77: 1708–1718
16. Choi VM, Herrou J, Hecht AL, Teoh WP, Turner JR, Crosson S, Bubeck Wardenburg J (2016) Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice. Nat Med 22: 563–567
17. Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620–625
18. Zitomersky NL, Coyne MJ, Comstock LE (2011) Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut. Infect Immun 79: 2012–2020
19. Nagaro KJ, Phillips ST, Cheknis AK, Sambol SP, Zukowski WE, Johnson S, Gerding DN (2013) Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob Agents Chemother 57: 5266–5270
20. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, Heidelberg JF, Mekalanos JJ (2006) Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci USA 103: 1528–1533
21. MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S (2010) The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci USA 107: 19520–19524
22. Brooks TM, Unterweger D, Bachmann V, Kostiuk B, Pukatzki S (2013) Lytic activity of the Vibrio cholerae type VI secretion toxin VgrG-3 is inhibited by the antitoxin TsaB. J Biol Chem 288: 7618–7625
23. Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ (2013) Identification of T6SS-dependent effector and immunity proteins by Tn-seq in Vibrio cholerae. Proc Natl Acad Sci USA 110: 2623–2628
24. Fu Y, Waldor MK, Mekalanos JJ (2013) Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe 14: 652–663
25. Unterweger D, Miyata ST, Bachmann V, Brooks TM, Mullins T, Kostiuk B, Provenzano D, Pukatzki S (2014) The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition. Nat Commun 5: 3549
26. Russell AB, Wexler AG, Harding BN, Whitney JC, Bohn AJ, Goo YA, Tran BQ, Barry NA, Zheng H, Peterson SB et al (2014) A type VI secretion-related pathway in Bacteroidetes mediates interbacterial antagonism. Cell Host Microbe 16: 227–236
27. Coyne MJ, Roelofs KG, Comstock LE (2016) Type VI secretion systems of human gut Bacteroidales segregate into three genetic architectures, two of which are contained on mobile genetic elements. BMC Genom 17: 58
28. Wexler AG, Bao Y, Whitney JC, Bobay L-M, Xavier JB, Schofield WB, Barry NA, Russell AB, Tran BQ, Goo YA et al (2016) Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc Natl Acad Sci USA 113: 3639–3644
29. Chatzidaki-Livanis M, Geva-Zatorsky N, Comstock LE (2016) Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species. Proc Natl Acad Sci USA 113: 3627–3632
30. Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14: 20–32
31. Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK (2013) Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501: 426–429
32. Russell AB, Peterson SB, Mougous JD (2014) Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol 12: 137–148
33. Rabizadeh S, Rhee KJ, Wu S, Huso D, Gan CM, Golub JE, Wu X, Zhang M, Sears CL (2007) Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 13: 1475–1483
34. Sears CL, Islam S, Saha A, Arjumand M, Alam NH, Faruque AS, Salam MA, Shin J, Hecht D, Weintraub A et al (2008) Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis 47: 797–803
35. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL et al (2013) The long-term stability of the human gut microbiota. Science 341: 1237439–1237439
36. DeStefano Shields CE, Van Meerbeke SW, Housseau F, Wang H, Huso DL, Casero RA, O'Hagan HM, Sears CL (2016) Reduction of murine colon tumorigenesis driven by enterotoxigenic Bacteroides fragilis using cefoxitin treatment. J Infect Dis 214: 122–129
37. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A et al (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517: 205–208
38. Comstock LE, Coyne MJ, Tzianabos AO, Pantosti A, Onderdonk AB, Kasper DL (1999) Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect Immun 67: 3525–3532
39. Koropatkin NM, Cameron EA, Martens EC (2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10: 323–335
40. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367–1372
41. Choi H, Fermin D, Nesvizhskii AI (2008) Significance analysis of spectral count data in label-free shotgun proteomics. Mol Cell Proteomics 7: 2373–2385